Pharmacokinetics in medicine Flashcards

1
Q

What is variability in pharmacogenetics?

A

Variability is a serious problem that can result in:
* Lack of efficacy
* Unexpected harmful effects

Variability can be classified as pharmacokinetic or pharmacodynamic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the main causes of variability in drug response?

A
  • Age
  • Genetic factors
  • Immunological factors
  • Disease
  • Drug interactions
  • Ethnicity

The concept of ethnicity is questioned by anthropologists due to diversity within racial groups.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does age influence drug action?

A

Age influences drug action primarily due to less efficient drug elimination in newborns and older individuals.

Drugs commonly have greater and prolonged effects at the extremes of life due to inefficient elimination.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the Glomerular Filtration Rate (GFR) in newborns?

A

GFR in newborns, normalized to body surface area, is only about 20% of adult values.

Renally eliminated drugs have longer plasma elimination half-lives in neonates due to immature renal function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What happens to GFR with aging?

A

GFR declines gradually from around 20 years old, decreasing by about 25% at 50 years and 50% at 75 years.

This decline impacts drug elimination and can lead to toxicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are pharmacodynamic interactions?

A

Pharmacodynamic interactions modify the pharmacological effect of another drug without altering its concentration in tissue fluid.

An example is β-adrenoreceptor antagonists reducing the effectiveness of β-adrenoreceptor agonists.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are pharmacokinetic interactions?

A

Pharmacokinetic interactions alter the concentration of another drug at its site of action.

The major processes involved are absorption, distribution, metabolism, and excretion (ADME).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the role of genetic variation in drug responsiveness?

A

Genetic variation can influence drug response through rare genetic traits or complex multifactorial traits involving genetic and environmental factors.

Polymorphisms, such as SNPs, are common genetic variants that can influence drug response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is a single nucleotide polymorphism (SNP)?

A

SNPs are the most common genetic variations, occurring once every 300 bases in the human genome.

They can influence physiological function if located within or near a gene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the classical Mendelian model in pharmacogenetics?

A

The classical Mendelian model applies to single-gene disorders where a mutation in a single gene is the primary cause of the disorder.

These disorders typically have predictable inheritance patterns.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is acute intermittent porphyria?

A

Acute intermittent porphyria is an inherited disorder affecting porphyrin biosynthesis, characterized by mutations in the PBGD gene.

It can be triggered by environmental factors, including certain drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are some therapeutic drugs for acute intermittent porphyria?

A

Givosiran is a small interfering RNA that reduces ALA synthase mRNA, alleviating neurotoxin build-up implicated in polyphyria attacks.

This is an expensive but effective treatment option.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What challenges exist in pharmacogenetic testing adoption?

A

Challenges include:
* Barriers to implementation
* Reimbursement contingent on cost-effectiveness
* Need for randomized control trials

These factors hinder the widespread use of pharmacogenomics in clinical practice.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

True or False: Ethnic categories based on outward appearance are sufficient for personalizing medicine.

A

False

Comprehensive genetic testing offers a more accurate approach than outdated ethnic classifications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Fill in the blank: The _______ in drug metabolism can lead to serious conditions like kernicterus and ‘grey-baby’ syndrome.

A

[lack of conjugating activity in newborns]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do drug interactions account for adverse drug reactions?

A

Drug interactions account for 5%–20% of adverse drug reactions (ADRs), with approximately 30% of fatal ADRs due to drug interactions.

This highlights the importance of monitoring drug combinations, especially in elderly patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are informed prescribing strategies?

A

Strategies that consider complex multifactorial traits influencing drug response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What influences drug response?

A

Multiple genes, genetic variants, and environmental factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

True or False: The probability of drug benefit and harm is often a clear-cut distinction.

A

False

20
Q

What is a limitation of relying on a single predictive genetic biomarker?

A

It may lack precision in guiding treatment.

21
Q

What are key clinical setting considerations for pharmacogenetic research?

A

Research is mainly in resource-rich areas with predominantly white populations.

22
Q

What are the key steps in evaluating pharmacogenetic markers?

A
  • Confirmation of analytic and clinical validity
  • Demonstration of clinical utility
  • Health economic considerations
23
Q

What are pharmacogenetic evaluation tests linked to?

A

Variants of human leukocyte antigens (HLAs) linked to severe harmful drug reactions.

24
Q

What is an example of pharmacogenetic testing?

A

Warfarin testing combining genetic information about metabolism and target.

25
Q

What challenges exist in the translation of pharmacogenetic data into clinical practice?

A

Multiple hurdles from discovery to tailored treatment plan delivery.

26
Q

What facilitates the detection of genetic associations in pharmacogenetics?

A

Large throughput studies and electronic patient databases.

27
Q

What is a key question for clinicians regarding genetic tests?

A

Is this situation appropriate for requesting a genetic test?

28
Q

What does Trastuzumab (Herceptin) target?

A

HER2 receptor in breast cancer patients.

29
Q

Fill in the blank: Dasatinib and Imatinib are first-line _______ for chronic myeloid leukaemia.

A

[tyrosine kinase inhibitors]

30
Q

What mutation confers resistance to dasatinib?

A

Mutation T315I in BCR/ABL.

31
Q

What types of treatments are included for cystic fibrosis?

A
  • Channel potentiators
  • Correctors
32
Q

What are Thiopurine drugs used for?

A

To treat leukaemia and immunosuppression in inflammatory disorders.

33
Q

What enzyme detoxifies Thiopurine drugs?

A

Thiopurine S methyltransferase (TPMT) and xanthine oxidase.

34
Q

What is the significance of 5-FU related compounds?

A

Used to treat solid tumours but have a narrow therapeutic window.

35
Q

What accounts for 20-30% of cases with life-threatening toxicity to 5-FU?

A

4 main clinically important genetic variants of DPYD.

36
Q

What is Abacavir used to treat?

A

HIV infection.

37
Q

What variant is linked to adverse effects of Abacavir?

A

HLA variant HLA-B*5701.

38
Q

What severe reactions can Carbamazepine cause?

A

Stevens-Johnson syndrome and toxic epidermal necrolysis.

39
Q

Which allele is associated with Carbamazepine adverse effects?

A

HLA-B*1502.

40
Q

True or False: Lacosamide shows clinically relevant differences in exposure based on CYP2C19 status.

A

False

41
Q

What do twin studies and single gene disorders demonstrate?

A

Susceptibility to adverse effects can be genetically determined.

42
Q

What types of single-gene disorders exist?

A
  • Autosomal recessive
  • Autosomal dominant
  • X-linked
  • Maternally inherited mitochondrial disorders
43
Q

What does pharmacogenomic testing offer?

A

Potential for more precise personalized therapeutics.

44
Q

What is required for pharmacogenomic testing to be effective?

A

High-quality trial evidence of clinical utility.

45
Q

What remains the key goal in pharmacogenomic research?

A

To consistently demonstrate that tests improve outcomes.